vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Atlanta Braves Holdings, Inc. (BATRA). Click either name above to swap in a different company.
Atlanta Braves Holdings, Inc. is the larger business by last-quarter revenue ($61.3M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -67.6%, a 47.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 17.6%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -52.5%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Atlanta Braves Holdings, Inc. is a sports and entertainment holding company that owns and operates the Atlanta Braves MLB franchise. It also manages adjacent mixed-use real estate, live events, merchandise sales, and media operations, serving fans across the U.S. Southeast and global baseball audiences.
ABCL vs BATRA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $61.3M |
| Net Profit | $-8.9M | $-41.4M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | -81.2% |
| Net Margin | -19.9% | -67.6% |
| Revenue YoY | 788.4% | 17.6% |
| Net Profit YoY | 73.9% | -116.7% |
| EPS (diluted) | $-0.03 | $-0.64 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $61.3M | ||
| Q3 25 | $9.0M | $311.5M | ||
| Q2 25 | $17.1M | $312.4M | ||
| Q1 25 | $4.2M | $47.2M | ||
| Q4 24 | $5.0M | $52.1M | ||
| Q3 24 | $6.5M | $290.7M | ||
| Q2 24 | $7.3M | $282.9M | ||
| Q1 24 | $10.0M | — |
| Q4 25 | $-8.9M | $-41.4M | ||
| Q3 25 | $-57.1M | $30.0M | ||
| Q2 25 | $-34.7M | $29.5M | ||
| Q1 25 | $-45.6M | $-41.4M | ||
| Q4 24 | — | $-19.1M | ||
| Q3 24 | $-51.1M | $10.0M | ||
| Q2 24 | $-36.9M | $29.1M | ||
| Q1 24 | $-40.6M | — |
| Q4 25 | -63.7% | -81.2% | ||
| Q3 25 | -851.8% | 12.5% | ||
| Q2 25 | -290.2% | 13.4% | ||
| Q1 25 | -1479.6% | -94.2% | ||
| Q4 24 | — | -35.8% | ||
| Q3 24 | -1439.4% | 2.2% | ||
| Q2 24 | -1276.2% | 8.8% | ||
| Q1 24 | -551.5% | — |
| Q4 25 | -19.9% | -67.6% | ||
| Q3 25 | -637.8% | 9.6% | ||
| Q2 25 | -203.3% | 9.4% | ||
| Q1 25 | -1077.2% | -87.7% | ||
| Q4 24 | — | -36.7% | ||
| Q3 24 | -785.4% | 3.4% | ||
| Q2 24 | -504.3% | 10.3% | ||
| Q1 24 | -408.0% | — |
| Q4 25 | $-0.03 | $-0.64 | ||
| Q3 25 | $-0.19 | $0.47 | ||
| Q2 25 | $-0.12 | $0.46 | ||
| Q1 25 | $-0.15 | $-0.66 | ||
| Q4 24 | — | $-0.29 | ||
| Q3 24 | $-0.17 | $0.16 | ||
| Q2 24 | $-0.13 | $0.46 | ||
| Q1 24 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $99.9M |
| Total DebtLower is stronger | — | $738.6M |
| Stockholders' EquityBook value | $966.9M | $526.0M |
| Total Assets | $1.4B | $1.6B |
| Debt / EquityLower = less leverage | — | 1.40× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $99.9M | ||
| Q3 25 | $83.2M | $82.2M | ||
| Q2 25 | $92.4M | $96.2M | ||
| Q1 25 | $159.3M | $244.7M | ||
| Q4 24 | $156.3M | $110.1M | ||
| Q3 24 | $126.6M | $100.9M | ||
| Q2 24 | $148.3M | $121.2M | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $738.6M | ||
| Q3 25 | — | $759.9M | ||
| Q2 25 | — | $703.1M | ||
| Q1 25 | — | $699.5M | ||
| Q4 24 | — | $617.1M | ||
| Q3 24 | — | $640.1M | ||
| Q2 24 | — | $600.0M | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $526.0M | ||
| Q3 25 | $964.0M | $560.3M | ||
| Q2 25 | $1.0B | $522.8M | ||
| Q1 25 | $1.0B | $486.1M | ||
| Q4 24 | $1.1B | $524.2M | ||
| Q3 24 | $1.1B | $530.4M | ||
| Q2 24 | $1.1B | $512.7M | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $1.4B | $1.6B | ||
| Q3 25 | $1.4B | $1.7B | ||
| Q2 25 | $1.4B | $1.7B | ||
| Q1 25 | $1.3B | $1.7B | ||
| Q4 24 | $1.4B | $1.5B | ||
| Q3 24 | $1.4B | $1.6B | ||
| Q2 24 | $1.4B | $1.6B | ||
| Q1 24 | $1.5B | — |
| Q4 25 | — | 1.40× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.34× | ||
| Q1 25 | — | 1.44× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $26.4M |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $26.4M | ||
| Q3 25 | $-52.6M | $-88.8M | ||
| Q2 25 | $-32.4M | $-8.1M | ||
| Q1 25 | $-11.6M | $95.8M | ||
| Q4 24 | $-108.6M | $28.9M | ||
| Q3 24 | $-28.9M | $-69.0M | ||
| Q2 24 | $-30.0M | $-34.3M | ||
| Q1 24 | $-41.7M | — |
| Q4 25 | $-44.6M | — | ||
| Q3 25 | $-61.5M | — | ||
| Q2 25 | $-45.8M | $-82.3M | ||
| Q1 25 | $-22.2M | $76.3M | ||
| Q4 24 | $-187.0M | $16.8M | ||
| Q3 24 | $-47.4M | $-85.5M | ||
| Q2 24 | $-50.1M | $-64.1M | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | — | ||
| Q3 25 | -687.0% | — | ||
| Q2 25 | -267.9% | -26.3% | ||
| Q1 25 | -524.0% | 161.5% | ||
| Q4 24 | -3702.8% | 32.3% | ||
| Q3 24 | -728.4% | -29.4% | ||
| Q2 24 | -683.8% | -22.7% | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | 0.0% | ||
| Q3 25 | 99.7% | 0.0% | ||
| Q2 25 | 78.2% | 23.7% | ||
| Q1 25 | 251.1% | 41.3% | ||
| Q4 24 | 1552.7% | 23.2% | ||
| Q3 24 | 284.6% | 5.7% | ||
| Q2 24 | 274.6% | 10.5% | ||
| Q1 24 | 242.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -2.96× | ||
| Q2 25 | — | -0.28× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -6.89× | ||
| Q2 24 | — | -1.18× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
BATRA
| Baseball | $34.8M | 57% |
| Mixed Use Development Segment | $26.5M | 43% |
